A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy
Clinical trial NCT05470985 · TERMINATED
Trial details
- NCT number
- NCT05470985
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-22
- Primary completion
- 2024-09-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.